Back to Search
Start Over
Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort
- Source :
- Cancer Causes & Control, Largent, Joan A.; Bernstein, Leslie; Horn-Ross, Pamela L.; Marshall, Sarah F.; Neuhausen, Susan; Reynolds, Peggy; et al.(2010). Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer Causes & Control: An International Journal of Studies of Cancer in Human Populations, 21(10), pp 1615-1624. doi: 10.1007/s10552-010-9590-x. Retrieved from: http://www.escholarship.org/uc/item/9548j4gr, Largent, JA; Bernstein, L; Horn-Ross, PL; Marshall, SF; Neuhausen, S; Reynolds, P; et al.(2010). Hypertension, antihypertensive medication use, and breast cancer risk in the California teachers study cohort. Cancer Causes and Control, 21(10), 1615-1624. doi: 10.1007/s10552-010-9590-x. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/1d53x742
- Publication Year :
- 2010
- Publisher :
- Springer Netherlands, 2010.
-
Abstract
- Background: We investigated the association between hypertension, antihypertensive (AH) medication use, and breast cancer in a large prospective study, the California Teachers Study (CTS). Methods: Information on history of hypertension and lifetime regular use of AH medications was collected from 114,549 women in 1995-1996. Among them, 4,151 invasive breast cancers were diagnosed between 1995 and 2006. Additional information on AH use was collected from 73,742 women in 2000-2001, and 1,714 of these women were subsequently diagnosed with breast cancer. Cox proportional hazards regression was used to estimate relative risks (RR) and 95% confidence intervals (CI) for breast cancer. Results: Use of AH medication for ≥5 years, when compared with no use, was associated with a modest increased risk of invasive breast cancer (RR = 1.18, 95%CI 1.02-1.36). This increased risk appeared to be confined to estrogen receptor (ER)-positive tumors (RR = 1.21, 95%CI 1.03-1.43) and pre-/peri-menopausal women (RR = 1.58, 95%CI 1.11-2.25). Conclusions: Increased risk of invasive breast cancer was observed for long-term (≥5 years) AH use, and this appeared to be confined to ER + breast cancer and younger women. © 2010 The Author(s).
- Subjects :
- Adult
medicine.medical_specialty
Cancer Research
Epidemiology
Biomedicine general
Breast Neoplasms
030204 cardiovascular system & hematology
California
Cohort Studies
03 medical and health sciences
0302 clinical medicine
Breast cancer
Risk Factors
Internal medicine
Medicine
Humans
Prospective Studies
Prospective cohort study
Antihypertensive Agents
Aged
Proportional Hazards Models
Gynecology
Original Paper
business.industry
Proportional hazards model
Antihypertensive medication
Public health
Age Factors
Hematology
Middle Aged
medicine.disease
nervous system diseases
3. Good health
Biomedicine
Oncology
Receptors, Estrogen
030220 oncology & carcinogenesis
Cohort
Hypertension
Female
Menopause
business
Risk assessment
Public Health/Gesundheitswesen
Cohort study
Subjects
Details
- Language :
- English
- ISSN :
- 15737225 and 09575243
- Volume :
- 21
- Issue :
- 10
- Database :
- OpenAIRE
- Journal :
- Cancer Causes & Control
- Accession number :
- edsair.doi.dedup.....d6e4bf8d5029a17c7ef6460b69619be8
- Full Text :
- https://doi.org/10.1007/s10552-010-9590-x.